AI Detects Eye Inflammation Linked to Age-Related Macular Degeneration Drugs

Researchers develop AI to spot inflammation from anti-VEGF drugs.

Machine learning analyzes OCT scans for early signs.

Achieves 76% accuracy before treatment, 81% at injection.

Early detection allows timely treatment adjustments.

Potential to prevent vision loss in nAMD patients.